Photodynamic therapy for choroidal neovascularization in patients with multifocal choroiditis and panuveitis

European Journal of Ophthalmology

Volumn 16, Issue 1, 2006, Pages 111-118

  Gerth, Christina ^a   Spital, G ^a   Lommatzsch, A ^a   Heiligenhaus, A ^a   Pauleikhoff, D ^a  

^a ST FRANZISKUS HOSPITAL   (Germany)

Author keywords

CNV; Multifocal choroiditis; PDT; Uveitis

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHOROIDITIS; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; INFLAMMATION; MALE; MORPHOLOGY; PATIENT MONITORING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RISK FACTOR; SCAR; SUBRETINAL NEOVASCULARIZATION; TREATMENT FAILURE; TREATMENT INDICATION; TREATMENT OUTCOME; UVEITIS; VISION; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 33645552838     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067210601600118     Document Type: Article

References (28)

1. Schmidt-Erfurth U. Minimal invasive Behandlung der choriodalen Neovaskularisation. Ophthalmologe 1998; 95: 725-31.
2. Schmidt-Erfurth U, Miller JW, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of retreatments in a phase 1 and 2 study. Arch Ophthalmol 1999; 117: 1177-87.
3. Miller JW, Schmidt-Erfurth U, Sickenberg M, et al. Photodynamic therapy with verteporfin for choroidal neovascularization caused by age-related macular degeneration: results of a single treatment in a phase 1 and 2 study. Arch Ophthalmol 1999; 117: 1161-73.
4. Bressler NM. Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 2001; 119: 198-207.
5. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000; 118: 327-36.
6. Ergun E, Heinzl H, Stur M. Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 2004; 138: 434-8.
7. Inagaki M, Harada T, Kiribuchi T, Ohashi T, Majima J. Subfoveal choroidal neovascularization in uveitis. Ophthalmologica 1996; 201: 229-33.
8. Fine SL, Owens SL, Haller JA, Knox DL, Patz A. Choroidal neovascularization as a late complication of ocular toxoplasmosis. Am J Ophthalmol 1981; 91: 318-22.
9. Godel V, Baruch E, Lazar M. Late development of chorioretinal lesions in birdshot retinochoroidopathy. Ann Ophthalmol 1989; 21: 49-52.
10. Krill AE, Archer D. Choroidal neovascularization in multifocal (presumed histoplasmin) choroiditis. Arch Ophthalmol 1970; 84: 595-604.
11. Callanan D, Gass JD. Multiple choroiditis and choroidal neovascularization associated with the multiple evanescent white dot and acute idiopathic blind spot enlargement syndrome. Ophthalmology 1992; 99: 1678-85.
12. Read RW, Rechodouni A, Butani N, et al. Complications and prognostic factors in Vogt-Koyanagi-Harada disease. Am J Ophthalmol 2001; 131: 599-606.
13. Brown J, Folk JC, Reddy CV, Kimura AE. Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. Ophthalmology 1996; 103: 1100-5.
14. Monshizadeh R, Ashrafzadeh MT, Rumelt S. Choroidal neovascular membrane: a late complication of inactive Toxocara chorioretinitis. Retina 2000; 20: 219-20.
15. Macular Photocoagulation Study Group. Argon laser photocoagulation for neovascular maculopathy. Three-year results from randomized clinical trials. Arch Ophthalmol 1986; 104: 694-700.
16. Macular Photocoagulation Study Group. Laser photocoagulation for neovascular lesions nasal to the fovea. Results from clinical trials for lesions secondary to ocular histoplasmosis or idiopathic causes. Arch Ophthalmol 1995; 113: 56-61.
17. Fine SL, Wood WJ, Isernhagen RD, et al. Laser treatment for subfoveal neovascular membranes in ocular histoplasmosis syndrome: results of a pilot randomized clinical trial. Arch Ophthalmol 1993; 111: 19-20.
18. Berger AS, Conway M, Del Priore LV, Walker RS, Pollack JS, Kaplan HJ. Submacular surgery for subfoveal choroidal neovascular membranes in patients with presumed ocular histoplasmosis. Arch Ophthalmol 1997; 115: 991-6.
19. Holekamp NM, Thomas MA, Dickinson JD, Valluri S. Surgical removal of subfoveal choroidal neovascularization in presumed ocular histoplasmosis: stability of early visual results. Ophthalmology 1997; 104: 22-6.
20. Spaide RF, Freund KB, Slakter J, Sorenson J, Yannuzzi LA, Fisher Y. Treatment of subfoveal choroidal neovascularization associated with multifocal choroiditis and panuveitis with photodynamic therapy. Retina 2002; 22: 545-9.
21. Rogers AH, Duker JS, Nichols N, Baker BJ. Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults. Ophthalmology 2003; 110: 1315-20.
22. Wachtlin J, Heimann H, Behme T, Foerster MH. Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases. Graefes Arch Clin Exp Ophthalmol 2003; 241: 899-906.
23. Parodi MB, Di Crecchio L, Lanzetta P, Polito A, Bandello F, Ravalico G. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization associated with multifocal choroiditis. Am J Ophthalmol 2004; 138: 263-9.
24. Leslie T, Lois N, Christopoulou D, Olson JA, Forrester JV. Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression. Br J Ophthalmol 2005; 89: 147-50.
25. Vitale AT, Kalpaxis JG. Multifocal choroiditis and panuveitis. In: Foster CS, Vitale AT, eds. Diagnosis and Treatment of Uveitis. Philadelphia: W.B. Saunders Company; 2000: 757-65.
26. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 2002; 22: 6-18.
27. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin. Two-year results of 2 randomized clinical trials-TAP Report 2. Arch Ophthalmol 2001; 119: 198-207.
28. Spaide RF, Sorenson J, Maranan L. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization. Ophthalmology 2003; 110: 1517-25.